Objective:To compare the efficacy of lobectomy and wedge resection for stage ⅠA non-small cell lung cancer(NSCLC).Methods:The clinical data of 75 patients with stage IA NSCLC who underwent lobectomy or wedge resection in our hospital from June 2021 to January 2023 were retrospectively collected.The patients were divided into an observation group(n=44)and a control group(n=31)according to the surgical procedure.Retrospective methods were used to collect clinical data from the two groups of patients,including operation time,intraoperative blood loss,postoperative pain level,length of hospital stay,complications during hospitalization,quality of life at 3 months after surgery,and quality of life at 1 year after surgery.The data were statistically analyzed to compare the clinical efficacy of the two groups.Results:The operation time,intraoperative blood loss,postoperative pain level,and hospitalization time in the observation group were significantly lower than those in the control group(P<0.05),but there was no significant difference in the catheterization time between the two groups(P>0.05).There was no significant difference in the incidence of postoperative complications between the two groups during hospitalization(P>0.05).At 3 years after surgery,the quality of life score of patients in the observation group was higher than that of the control group,and the difference was statistically significant(P<0.05).There were no significant differences in the recurrence rate,distant metastasis rate,and mortality rate between the two groups one year after surgery(P>0.05).Conclusion:Compared with lobectomy,wedge resection can improve the surgical condition of patients with stage IA NSCLC,which promotes postoperative recovery and enhances quality of life.
维普
万方数据